BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38263395)

  • 1. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
    Kasai A; Miyoshi J; Sato Y; Okamoto K; Miyamoto H; Kawanaka T; Tonoiso C; Harada M; Goto M; Yoshida T; Haga A; Takayama T
    Sci Rep; 2024 Jan; 14(1):2039. PubMed ID: 38263395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
    Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
    Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A machine learning approach using
    Qi WX; Li S; Xiao J; Li H; Chen J; Zhao S
    Front Immunol; 2024; 15():1351750. PubMed ID: 38352868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
    Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
    BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative CT radiomics of esophageal squamous cell carcinoma and lymph node to predict nodal disease with a high diagnostic capability.
    Wu YP; Wu L; Ou J; Cao JM; Fu MY; Chen TW; Ouchi E; Hu J
    Eur J Radiol; 2024 Jan; 170():111197. PubMed ID: 37992611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
    Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
    BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.
    Guo L; Liu A; Geng X; Zhao Z; Nie Y; Wang L; Liu D; Li Y; Li Y; Li D; Wang Q; Li Z; Liu X; Li M
    Thorac Cancer; 2024 Apr; 15(12):947-964. PubMed ID: 38480505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Lam KO; Wong IYH; Law SYK; Chiu KWH; Vardhanabhuti V; Fu J
    Radiother Oncol; 2021 Jan; 154():6-13. PubMed ID: 32941954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT radiomics features to predict lymph node metastasis in advanced esophageal squamous cell carcinoma and to discriminate between regional and non-regional lymph node metastasis: a case control study.
    Ou J; Wu L; Li R; Wu CQ; Liu J; Chen TW; Zhang XM; Tang S; Wu YP; Yang LQ; Tan BG; Lu FL
    Quant Imaging Med Surg; 2021 Feb; 11(2):628-640. PubMed ID: 33532263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
    Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
    Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential value of CT-based comprehensive nomogram in predicting occult lymph node metastasis of esophageal squamous cell paralaryngeal nerves: a two-center study.
    Xue T; Wan X; Zhou T; Zou Q; Ma C; Chen J
    J Transl Med; 2024 Apr; 22(1):399. PubMed ID: 38689366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a survival prediction model for esophageal squamous cell carcinoma based on CT and histopathological images.
    Wang J; Wu LL; Zhang Y; Ma G; Lu Y
    Phys Med Biol; 2021 Jul; 66(14):. PubMed ID: 34192686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography-based radiomics analysis to predict lymphovascular invasion in esophageal squamous cell carcinoma.
    Peng H; Yang Q; Xue T; Chen Q; Li M; Duan S; Cai B; Feng F
    Br J Radiol; 2022 Feb; 95(1130):20210918. PubMed ID: 34908477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
    Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
    J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
    Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT radiomics in the identification of preoperative understaging in patients with clinical stage T1-2N0 esophageal squamous cell carcinoma.
    Zhao B; Yan S; Jia ZY; Zhu HT; Shi YJ; Li XT; Qu JR; Sun YS
    Quant Imaging Med Surg; 2023 Dec; 13(12):7996-8008. PubMed ID: 38106287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089).
    Peng G; Zhan Y; Wu Y; Zeng C; Wang S; Guo L; Liu W; Luo L; Wang R; Huang K; Huang B; Chen J; Chen C
    Front Oncol; 2022; 12():988859. PubMed ID: 36387160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
    Zhu Y; Yao W; Xu BC; Lei YY; Guo QK; Liu LZ; Li HJ; Xu M; Yan J; Chang DD; Feng ST; Zhu ZH
    BMC Cancer; 2021 Oct; 21(1):1167. PubMed ID: 34717582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography-based radiomic analysis for prediction of treatment response to salvage chemoradiotherapy for locoregional lymph node recurrence after curative esophagectomy.
    Gu L; Liu Y; Guo X; Tian Y; Ye H; Zhou S; Gao F
    J Appl Clin Med Phys; 2021 Nov; 22(11):71-79. PubMed ID: 34614265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.